Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5500-5506

  Rijken, Marcus J ^a   McGready, Rose ^a,b,c   Phyo, Aung Phae ^a   Lindegardh, Niklas ^b,c   Tarning, Joel ^b,c   Laochan, Natthapon ^a   Than, Hla Hla ^a   Mu, Oh ^a   Win, Aye Kyi ^a   Singhasivanon, Pratap ^b   White, Nicholas ^b,c   Nosten, François ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; CLINDAMYCIN; DIHYDROARTEMISININ PLUS PIPERAQUINE; MEFLOQUINE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG MEGADOSE; FEMALE; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; MALARIA FALCIPARUM; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; PARITY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIMIGRAVIDA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HALF-LIFE; HUMANS; MALARIA, FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; QUINOLINES; THAILAND; YOUNG ADULT;

EID: 81555206674     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05067-11     Document Type: Article

References (38)

1. Annerberg, A., et al. 2011. A small amount of fat does not affect piperaquine exposure in patients with malaria. Antimicrob. Agents Chemother. 55:3971-3976.
2. Arinaitwe, E., et al. 2009. Artemether-lumefantrine versus dihydroartemisinin- piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin. Infect. Dis. 49:1629-1637.
3. Ashley, E. A., et al. 2005. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin. Infect. Dis. 41: 425-432. (Pubitemid 41099632)
4. Bassat, Q., et al. 2009. Dihydroartemisinin-piperaquine and artemetherlumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One 4:e7871.
5. Brockman, A., et al. 2000. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans. R. Soc. Trop. Med. Hyg. 94:537-544.
6. Chinh, N. T., et al. 2009. Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects. Antimicrob. Agents Chemother. 53:828-831.
7. Gordi, T., et al. 2005. A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction. Br. J. Clin. Pharmacol. 59:189-198. (Pubitemid 40208855)
8. Grande, T., et al. 2007. A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS One 2:e1101.
9. Hong, X., et al. 2008. Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers. Biopharm. Drug Dispos. 29:237-244. (Pubitemid 351802846)
10. Hung, T. Y., et al. 2004. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br. J. Clin. Pharmacol. 57:253-262.
11. Karunajeewa, H. A., et al. 2008. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob. Agents Chemother. 52:237-243.
12. Le Thi, D. T., N. H. Le, C. H. Nguyen, D. Phan Thi, and K. Na-Bangchang. Pharmacokinetics of a five-day oral dihydroartemisinin monotherapy regimen in patients with uncomplicated falciparum malaria. Drug Metab. Pharmacokinet. 23:158-164.
13. McGready, R., et al. 2003. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur. J. Clin. Pharmacol. 59:545-552. (Pubitemid 37368905)
14. McGready, R., et al. 2006. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. Eur. J. Clin. Pharmacol. 62:1021-1031. (Pubitemid 44786494)
15. McGready, R., et al. 2006. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. Eur. J. Clin. Pharmacol. 62:367-371.
16. McGready, R., et al. 2008. A randomised controlled trial of artemetherlumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. PLoS Med. 5:e253.
17. Morris, C. A., et al. 2011. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria. Malar J. 10:114.
18. Na-Bangchang, K., A. Thanavibul, P. Tippawangkosol, and J. Karbwang. 2005. Pharmacokinetics of the four combination regimens of dihydroartemisinin/ mefloquine in acute uncomplicated falciparum malaria. Southeast Asian J. Trop. Med. Public Health 36:23-33. (Pubitemid 40576990)
19. Newton, P. N., et al. 2008. Characterization of "Yaa Chud" Medicine on the Thailand-Myanmar border: selecting for drug-resistant malaria and threatening public health. Am. J. Trop. Med. Hyg. 79:662-669.
20. Nguyen, D. V., et al. 2009. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam. Antimicrob. Agents Chemother. 53:3534-3537.
21. Nguyen, T. C., et al. 2008. Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects. Am. J. Trop. Med. Hyg. 79:620-623.
22. Nosten, F., F. ter Kuile, L. Maelankirri, B. Decludt, and N. J. White. 1991. Malaria during pregnancy in an area of unstable endemicity. Trans. R. Soc. Trop. Med. Hyg. 85:424-429.
23. Onyamboko, M. A., et al. 2011. Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. Malar. J. 10:49.
24. Poespoprodjo, J. R., et al. 2008. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin. Infect. Dis. 46:1374-1381. (Pubitemid 351589936)
25. Price, R. N., et al. 2007. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Antimicrob. Agents Chemother. 51:4090-4097. (Pubitemid 350057809)
26. Rijken, M. J., et al. 2009. Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border. Ultrasound Obstet. Gynecol. 34:395-403.
27. Rijken, M. J., et al. 2008. Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Am. J. Trop. Med. Hyg. 78:543-545. (Pubitemid 351845153)
28. Rijken, M. J., et al. 2011. Malaria in pregnancy: the difficulties in measuring birthweight. BJOG 118:671-678.
29. Roshammar, D., T. N. Hai, S. Friberg Hietala, N. Van Huong, and M. Ashton. 2006. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur. J. Clin. Pharmacol. 62:335-341.
30. Sim, I. K., T. M. Davis, and K. F. Ilett. 2005. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob. Agents Chemother. 49:2407-2411.
31. Smithuis, F., et al. 2006. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an openlabel randomised comparison. Lancet 367:2075-2085. (Pubitemid 43949291)
32. Tarning, J., et al. 2008. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob. Agents Chemother. 52:1052-1061. (Pubitemid 351358388)
33. Tarning, J., et al. 2005. Pitfalls in estimating piperaquine elimination. Antimicrob. Agents Chemother. 49:5127-5128. (Pubitemid 41778931)
34. Tarning, J., et al. 2009. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 53:3837-3846.
35. Tran, T. H., et al. 2004. Dihydroartemisinin-piperaquine against multidrugresistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363:18-22.
36. White, N. J., R. M. McGready, and F. H. Nosten. 2008. New medicines for tropical diseases in pregnancy: catch-22. PLoS Med. 5:e133.
37. WHO. 2010. Guidelines for the treatment of malaria, 2nd ed. World Health Organization, Geneva, Switzerland.
38. Zwang, J., et al. 2009. Safety and efficacy of dihydroartemisinin- piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 4:e6358.